Methods and compositions for vitamin K epoxide reductase
View Patent ↗The present invention provides a method of identifying a human subject having increased or decreased sensitivity to warfarin, comprising detecting in the subject the presence of a single nucleotide polymorphism in the VKOR gene, wherein the single nucleotide polymorphism is correlated with increased or decreased sensitivity to warfarin, thereby identifying the subject having increased or decreased sensitivity to warfarin.
1. A method of producing a vitamin K dependent protein, comprising:
a) culturing a cell that comprises:
i) a nucleotide sequence encoding a vitamin K dependent protein;
ii) a heterologous nucleotide sequence encoding a vitamin K dependent carboxylase;
iii) a heterologous nucleic acid comprising a nucleotide sequence selected from the group consisting of:
1) the nucleotide sequence of SEQ ID NO:9;
2) a nucleotide sequence that encodes the amino acid sequence of SEQ ID NO:10;
3) a nucleotide sequence having at least 95% identity with the nucleotide sequence of SEQ ID NO:9 and that encodes a vitamin K epoxide reductase (VKOR);
4) a nucleotide sequence that hybridizes with the complement of the nucleotide sequence of (1) or (2) above under stringent conditions as represented by hybridization conditions of 0.5M NaHPO 4 , 7% sodium dodecyl sulfate (SDS), 1 mM EDTA at 65° C. and wash conditions of 0.1×SSC/0.1% SDS at 68° C. and that encodes a VKOR;
5) a nucleotide sequence that encodes an amino acid sequence having at least 95% identity with the amino acid sequence of SEQ ID NO:10 and that encodes a VKOR and
6) a nucleotide sequence that differs from the nucleotide sequence of(1), (2), (3), (4) or (5) above due to the degeneracy of the genetic code and that encodes a VKOR; and
(iv) vitamin K,
under conditions whereby the vitamin K dependent protein is produced; and
b) harvesting the vitamin K dependent protein.
2. The method of claim 1 , wherein the cell is a mammalian cell.
3. The method of claim 1 , wherein the cell is a plant cell.
4. The method of claim 1 , wherein the cell is an insect cell.
5. The method of claim 1 , wherein the vitamin K dependent protein is selected from the group consisting of Factor VII, Factor IX, Factor X, Protein C, Protein S, prothrombin and any combination thereof.
6. An isolated transformed cell comprising:
a) a nucleotide sequence encoding a vitamin K dependent protein;
b) a heterologous nucleotide sequence encoding a vitamin K dependent carboxylase; and
c) a heterologous nucleic acid comprising a nucleotide sequence selected from the group consisting of:
1) the nucleotide sequence of SEQ ID NO:9;
2) a nucleotide sequence that encodes the amino acid sequence of SEQ ID NO:10;
3) a nucleotide sequence having at least 95% identity with the nucleotide sequence of SEQ ID NO:9 and that encodes a VKOR;
4) a nucleotide sequence that hybridizes with the complement of the nucleotide sequence of (1) or (2) above under stringent conditions as represented by hybridization conditions of 0.5M NaHPO 4 , 7% sodium dodecyl sulfate (SDS), 1 mM EDTA at 65° C. and wash conditions of 0.1×SSC/0.1% SDS at 68° C. and that encodes a VKOR:
5) a nucleotide sequence that encodes an amino acid sequence having at least 95% identity with the amino acid sequence of SEQ ID NO:10 and that encodes a VKOR; and
6) a nucleotide sequence that differs from the nucleotide sequence of (1), (2), (3), (4) or (5) above due to the degeneracy of the genetic code and that encodes a VKOR.
7. The cell of claim 6 , wherein the cell is a mammalian cell.
8. The cell of claim 6 , wherein the cell is a plant cell.
9. The cell of claim 6 , wherein the cell is an insect cell.
10. The cell of claim 6 , wherein the vitamin K dependent protein is selected from the group consisting of Factor VII, Factor IX, Factor X, Protein C, Protein S, prothrombin and any combination thereof.